181 related articles for article (PubMed ID: 30347759)
21. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Kaczkowski B; Tanaka Y; Kawaji H; Sandelin A; Andersson R; Itoh M; Lassmann T; Hayashizaki Y; Carninci P; Forrest AR;
Cancer Res; 2016 Jan; 76(2):216-26. PubMed ID: 26552699
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Huang X; Stern DF; Zhao H
Sci Rep; 2016 Feb; 6():20567. PubMed ID: 26837275
[TBL] [Abstract][Full Text] [Related]
24. PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.
Di Zazzo E; De Rosa C; Abbondanza C; Moncharmont B
Biology (Basel); 2013 Jan; 2(1):107-41. PubMed ID: 24832654
[TBL] [Abstract][Full Text] [Related]
25. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
26. Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
[TBL] [Abstract][Full Text] [Related]
28. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
[TBL] [Abstract][Full Text] [Related]
29. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
30. DriverDBv2: a database for human cancer driver gene research.
Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
[TBL] [Abstract][Full Text] [Related]
31. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
32. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
33. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.
Fang W; Piao Z; Simon D; Sheu JC; Huang S
Genes Chromosomes Cancer; 2000 Jul; 28(3):269-75. PubMed ID: 10862032
[TBL] [Abstract][Full Text] [Related]
34. PRDM12 in Health and Diseases.
Rienzo M; Di Zazzo E; Casamassimi A; Gazzerro P; Perini G; Bifulco M; Abbondanza C
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769459
[TBL] [Abstract][Full Text] [Related]
35. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
37. Making Use of Cancer Genomic Databases.
Creighton CJ
Curr Protoc Mol Biol; 2018 Jan; 121():19.14.1-19.14.13. PubMed ID: 29337373
[TBL] [Abstract][Full Text] [Related]
38.
Hadziselimovic F; Cathomas G; Verkauskas G; Dasevicius D; Stadler MB
Genes (Basel); 2018 Aug; 9(8):. PubMed ID: 30071651
[TBL] [Abstract][Full Text] [Related]
39. PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1.
Yang XH; Huang S
Genomics; 1999 Nov; 61(3):319-25. PubMed ID: 10552934
[TBL] [Abstract][Full Text] [Related]
40. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
